These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 15478074)

  • 41. Long-term follow-up of asymptomatic HIV-infected patients who discontinued antiretroviral therapy.
    Fernández Guerrero ML; Rivas P; Molina M; Garcia R; De Górgolas M
    Clin Infect Dis; 2005 Aug; 41(3):390-4. PubMed ID: 16007538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count.
    Martín-Echevarria E; Rodríguez-Zapata M; Torralba M; Fernández JM; Moreno A; Casado JL; Dronda F; Pérez-Elías MJ; Navas E; Moreno S
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1347-52. PubMed ID: 22283893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.
    Williams BG; Dye C
    Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.
    Dean GL; Edwards SG; Ives NJ; Matthews G; Fox EF; Navaratne L; Fisher M; Taylor GP; Miller R; Taylor CB; de Ruiter A; Pozniak AL
    AIDS; 2002 Jan; 16(1):75-83. PubMed ID: 11741165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study.
    Maruza M; Albuquerque MF; Braga MC; Barbosa MT; Byington R; Coimbra I; Moura LV; Batista JD; Diniz GT; Miranda-Filho DB; Lacerda HR; Rodrigues LC; Ximenes RA
    Int J Tuberc Lung Dis; 2012 May; 16(5):618-24. PubMed ID: 22410415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
    Hung CC; Chen MY; Hsiao CF; Hsieh SM; Sheng WH; Chang SC
    AIDS; 2003 Dec; 17(18):2615-22. PubMed ID: 14685055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mycobacterial diseases and HIV.
    Pozniak A
    J HIV Ther; 2002 Feb; 7(1):13-6. PubMed ID: 11956499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes of antituberculosis treatments at 18 months follow-up in TB-HIV co-infected patients on ART: a retrospective review of 166 cases.
    Chunpongthong P; Ko ZZ; Yeekian C; Luvira V; Pitisuttithum P
    J Med Assoc Thai; 2011 Jun; 94(6):664-70. PubMed ID: 21696073
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tuberculosis in HIV-infected patients: a comprehensive review.
    Aaron L; Saadoun D; Calatroni I; Launay O; Mémain N; Vincent V; Marchal G; Dupont B; Bouchaud O; Valeyre D; Lortholary O
    Clin Microbiol Infect; 2004 May; 10(5):388-98. PubMed ID: 15113314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients.
    Kwara A; Carter EJ; Rich JD; Flanigan TP
    AIDS Patient Care STDS; 2004 Jun; 18(6):341-7. PubMed ID: 15294084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune reconstitution inflammatory syndrome in HIV-infected patients with tuberculosis.
    Kiertiburanakul S
    J Med Assoc Thai; 2010 Feb; 93(2):257-64. PubMed ID: 20302011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections.
    Dronda F; Sobrino P; Hernández-Novoa B; Caro-Murillo AM; Montero M; Iribarren JA; Sanz J; Del Mar Alonso M; Labarga P; Bernal E; Moreno S;
    Curr HIV Res; 2011 Jun; 9(4):229-36. PubMed ID: 21631429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients.
    Morris L; Martin DJ; Bredell H; Nyoka SN; Sacks L; Pendle S; Page-Shipp L; Karp CL; Sterling TR; Quinn TC; Chaisson RE
    J Infect Dis; 2003 Jun; 187(12):1967-71. PubMed ID: 12792875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial.
    Amogne W; Aderaye G; Habtewold A; Yimer G; Makonnen E; Worku A; Sonnerborg A; Aklillu E; Lindquist L
    PLoS One; 2015; 10(5):e0122587. PubMed ID: 25966339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of tuberculosis on the course of HIV-infected patients with a high initial CD4 lymphocyte count.
    Mañas E; Pulido F; Peña JM; Rubio R; Gonzalez-García J; Costa R; Pérez-Rodríguez E; Del Palacio A
    Int J Tuberc Lung Dis; 2004 Apr; 8(4):451-7. PubMed ID: 15141738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changing sociodemographic and clinical characteristics of tuberculosis among HIV-infected patients, New York City, 1992-2005.
    Harris TG; Li J; Hanna DB; Munsiff SS
    Clin Infect Dis; 2010 Jun; 50(11):1524-31. PubMed ID: 20415570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania.
    Mugusi SF; Ngaimisi E; Janabi MY; Mugusi FM; Minzi OM; Sasi PG; Bakari M; Lindquist L; Aklillu E; Sandstrom EG
    Antivir Ther; 2012; 17(2):265-74. PubMed ID: 22293579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.
    Scholten JN; Driver CR; Munsiff SS; Kaye K; Rubino MA; Gourevitch MN; Trim C; Amofa J; Seewald R; Highley E; Fujiwara PI
    Clin Infect Dis; 2003 Dec; 37(12):1686-92. PubMed ID: 14689352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiretroviral initiation during or following treatment of TB.
    AIDS Alert; 2010 Jun; 25(6):69-70. PubMed ID: 20623832
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.